Literature DB >> 33704719

Transcript-Based Detection of Circulating Melanoma Cells.

Michael Morici1, Weitao Lin1, Elin S Gray2.   

Abstract

Circulating tumor cells (CTCs) are cancer cells shed by the primary tumor or its metastases that circulate in the peripheral blood. CTCs are potential seeds for metastases, and their detection may allow early uncovering of metastatic dissemination and disease prognostication. To fully ascertain the biomarker potential of melanoma CTCs, sensitive and reliable methods are required. Melanoma-specific transcript analysis has been widely utilized as a standard approach for measuring the presence of CTCs. Here we describe a method for the analysis of CTCs through the detection of specific transcripts in CTC-enriched fractions.

Entities:  

Keywords:  Circulating tumor cell (CTC); Droplet digital PCR (ddPCR ); Melanoma; Real-time PCR; Transcripts

Mesh：

Substances：

Year:  2021        PMID： 33704719     DOI： 10.1007/978-1-0716-1205-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  12 in total

Review 1.  Melanoma circulating tumor cells: Benefits and challenges required for clinical application.

Authors:  G Marsavela; C A Aya-Bonilla; M E Warkiani; E S Gray; M Ziman
Journal:  Cancer Lett       Date:  2018-03-14       Impact factor: 8.679

Review 2.  Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance.

Authors:  L Khoja; P Lorigan; C Dive; U Keilholz; A Fusi
Journal:  Ann Oncol       Date:  2014-06-06       Impact factor: 32.976

3.  Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.

Authors:  Anna L Reid; James B Freeman; Michael Millward; Melanie Ziman; Elin S Gray
Journal:  Clin Biochem       Date:  2014-12-16       Impact factor: 3.281

Review 4.  Liquid biopsy and minimal residual disease - latest advances and implications for cure.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Nat Rev Clin Oncol       Date:  2019-07       Impact factor: 66.675

5.  Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.

Authors:  James B Freeman; Elin S Gray; Michael Millward; Robert Pearce; Melanie Ziman
Journal:  J Transl Med       Date:  2012-09-15       Impact factor: 5.531

6.  Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.

Authors:  Elin S Gray; Anna L Reid; Samantha Bowyer; Leslie Calapre; Kelvin Siew; Robert Pearce; Lester Cowell; Markus H Frank; Michael Millward; Mel Ziman
Journal:  J Invest Dermatol       Date:  2015-04-01       Impact factor: 8.551

7.  Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells.

Authors:  Carlos Alberto Aya-Bonilla; Michael Morici; Xin Hong; Ashleigh Cavell McEvoy; Ryan Joseph Sullivan; James Freeman; Leslie Calapre; Muhammad Adnan Khattak; Tarek Meniawy; Michael Millward; Mel Ziman; Elin Solomonovna Gray
Journal:  Br J Cancer       Date:  2020-02-10       Impact factor: 7.640

8.  Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.

Authors:  Carlos A Aya-Bonilla; Gabriela Marsavela; James B Freeman; Chris Lomma; Markus H Frank; Muhammad A Khattak; Tarek M Meniawy; Michael Millward; Majid E Warkiani; Elin S Gray; Mel Ziman
Journal:  Oncotarget       Date:  2017-06-27

9.  Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells.

Authors:  Fabio Fachin; Philipp Spuhler; Joseph M Martel-Foley; Jon F Edd; Thomas A Barber; John Walsh; Murat Karabacak; Vincent Pai; Melissa Yu; Kyle Smith; Henry Hwang; Jennifer Yang; Sahil Shah; Ruby Yarmush; Lecia V Sequist; Shannon L Stott; Shyamala Maheswaran; Daniel A Haber; Ravi Kapur; Mehmet Toner
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

10.  Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.

Authors:  Xin Hong; Ryan J Sullivan; Mark Kalinich; Tanya Todorova Kwan; Anita Giobbie-Hurder; Shiwei Pan; Joseph A LiCausi; John D Milner; Linda T Nieman; Ben S Wittner; Uyen Ho; Tianqi Chen; Ravi Kapur; Donald P Lawrence; Keith T Flaherty; Lecia V Sequist; Sridhar Ramaswamy; David T Miyamoto; Michael Lawrence; Mehmet Toner; Kurt J Isselbacher; Shyamala Maheswaran; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-16       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.